A retrospective study of experience of tafamidis treatment for Japanese patients with wild-type transthyretin cardiac amyloidosis
Latest Information Update: 27 May 2022
At a glance
- Drugs Tafamidis meglumine (Primary)
- Indications Amyloidosis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 27 May 2022 New trial record
- 12 May 2022 Results published in the Circulation Journal